Laboratory Corp. of America Holdings  

(Public, NYSE:LH)   Watch this stock  
Find more results for LH
126.93
+0.55 (0.44%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 125.16 - 128.00
52 week 95.12 - 131.19
Open 126.28
Vol / Avg. 1.13M/840,992.00
Mkt cap 12.75B
P/E 21.46
Div/yield     -
EPS 5.92
Shares 100.30M
Beta 0.61
Inst. own 91%
May 14, 2015
Laboratory Corporation of America Holdings Annual Shareholders Meeting (Estimated) - 9:00AM EDT - Add to calendar
May 13, 2015
Laboratory Corporation of America Holdings Annual Shareholders Meeting - 9:00AM EDT - Add to calendar
Apr 27, 2015
Q1 2015 Laboratory Corporation of America Holdings Earnings Release - 9:30AM EDT - Add to calendar
Apr 27, 2015
Q1 2015 Laboratory Corporation of America Holdings Earnings Call - 9:00AM EDT - Add to calendar
Mar 10, 2015
Laboratory Corporation of America Holdings at Barclays Healthcare Conference - Webcast
Feb 20, 2015
Q4 2014 Laboratory Corporation of America Holdings Earnings Release
Feb 20, 2015
Q4 2014 Laboratory Corporation of America Holdings Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 7.93% 8.53%
Operating margin 14.48% 15.14%
EBITD margin - 19.52%
Return on average assets 6.62% 7.19%
Return on average equity 17.16% 19.25%
Employees 36,000 -
CDP Score - -

Address

358 S MAIN ST
BURLINGTON, NC 27215-5837
United States - Map
+1-336-2291127 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Laboratory Corporation of America Holdings is a clinical laboratory company. Through a network of laboratories, the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing and patient diagnosis, and in the monitoring and treatment of disease. The Company has also developed testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics, cardiovascular disease risk assessment, HCV diagnosis and monitoring, and clinical trials. The Company has a national network of 44 primary laboratories and 1,700 patient service centers (PSCs) along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain core tests and report the results to the physician quickly). Its clients include physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies and other independent clinical laboratories.

Officers and directors

David P. King Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Glenn A. Eisenberg Chief Financial Officer, Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Joseph L. Herring Chief Executive Officer- Covance Drug Development
Age: 59
Bio & Compensation  - Reuters
William E. Klitgaard President- Enlighten Health
Age: 62
Bio & Compensation  - Reuters
Lisa J. Uthgenannt Chief Human Resource Officer
Age: 54
Bio & Compensation  - Reuters
James T. Boyle Jr. Executive Vice President and Chief Executive Officer- LabCorp Diagnostics
Age: 58
Bio & Compensation  - Reuters
Edward T. Dodson Senior Vice President, Chief Accounting Officer, Principal Accounting Officer
Age: 61
Bio & Compensation  - Reuters
Lance V. Berberian Senior Vice President, Chief Information Officer
Age: 52
Bio & Compensation  - Reuters
F. Samuel Eberts III Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
Age: 55
Bio & Compensation  - Reuters
Mark Elliott Brecher M.D. Senior Vice President, Chief Medical Officer
Age: 58
Bio & Compensation  - Reuters